Searched for
DIGWAL
Piramal Pharma Q3 Results: Co reports loss as CDMO slowdown drags revenuePiramal Pharma swung to a Rs 136 crore Q3 loss as revenue fell 3%, hit by CDMO destocking, weak US biopharma funding, trade uncertainty and...- Piramal Pharma Q2 Results: Net profit jumps over 4-fold to Rs 23 cr; revenue at Rs 2,242 crPiramal Pharma reported a significant increase in consolidated net profit for Q2, growing from Rs 5 crore last year to Rs 23 crore. Revenue...
- In 3-5 years, Piramal Pharma can see 22- 25% EBITDA growth margins: Nandini PiramalNandini Piramal projects early teens revenue growth for FY25 and 22-25% EBITDA growth margins in 3-5 years. Revenue increase drives margin ...
- CMG biz to drive Piramal Healthcare growthThe Rs 2870 crore Piramal Healthcare is upbeat on the business potential for its custom manufacturing vertical for global pharma innovator ...
Load More- CMG biz to drive Piramal Healthcare growth